Studies have shown that activation of STAT3 in ovarian cancer leads to upregulation of MMP2 expression [48], and inhibition of STAT3 in pancreatic cancer cells results in down-regulation of MMP9 expression [49]. The gene discussed is MMP2; the disease is ovarian carcinoma.